According to Immutep's latest financial reports the company's total liabilities are $7.26 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-06-30 | $7.26 M | 30.54% |
2022-06-30 | $5.56 M | -15.4% |
2021-06-30 | $6.58 M | -27.98% |
2020-06-30 | $9.13 M | -19.45% |
2019-06-30 | $11.34 M | 13.78% |
2018-06-30 | $9.97 M | 53.88% |
2017-06-30 | $6.47 M | 19.87% |
2016-06-30 | $5.4 M | 11.94% |
2015-06-30 | $4.82 M | 84.09% |
2014-06-30 | $2.62 M | -19.42% |
2013-06-30 | $3.25 M | -28.63% |
2012-06-30 | $4.56 M | 67.85% |
2011-06-30 | $2.71 M | 46.14% |
2010-06-30 | $1.85 M | 240.67% |
2009-06-30 | $0.54 M | 203.37% |
2008-06-30 | $0.17 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Illumina ILMN | $4.36 B | 59,970.06% | ๐บ๐ธ USA |
FibroGen FGEN | $0.58 B | 7,958.80% | ๐บ๐ธ USA |
HTG Molecular Diagnostics
HTGM | $10.39 M | 42.97% | ๐บ๐ธ USA |